News | July 10, 2024
Lilly to acquire Morphic to improve outcomes for patients with inflammatory bowel disease
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The integration of SAP S/4HANA Cloud will equip Cupid Limited with a comprehensive suite of integrated applications,
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Imfinzi also recommended for patients with mismatch repair deficient disease
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
Combined entity is better positioned to compete in increasingly competitive generics industry
Subscribe To Our Newsletter & Stay Updated
